There are some ASX shares that I think investors could buy today and happily hold for the next decade.
And while there will undoubtedly be ups and downs along the way, I believe the following three shares have the quality and growth opportunities to deliver attractive long-term returns.
REA Group Ltd (ASX: REA)
The first ASX share I'd consider is REA Group. It is the operator of realestate.com.au, Australia's leading property website, which attracts millions of potential buyers and renters every month.
Its enormous audience makes it an essential advertising platform for real estate agents. And I believe that gives REA considerable pricing power.
Its latest quarterly update demonstrated this strength, with revenue increasing 11% to $450 million despite national property listings declining 2%.
Importantly, REA continues developing premium advertising products, property data services, and financial services that create additional revenue opportunities.
With its dominant market position and potential to generate more revenue from each property listing, I believe REA could deliver strong earnings growth over the next decade.
ResMed Inc. (ASX: RMD)
Another popular ASX share I'd happily buy and hold is ResMed, which develops medical devices and masks used to treat sleep apnoea.
I believe the healthcare company has an enormous opportunity ahead as awareness of sleep disorders improves and more people receive treatment.
And once patients begin therapy, they regularly need replacement masks and accessories, creating valuable recurring revenue.
For example, in its recent quarterly update, ResMed revealed revenue growth of 6% to US$1.4 billion, with mask and accessory sales increasing 10%.
With its established global market position, growing patient population, and ongoing investment in R&D, I think ResMed has plenty of growth ahead.
Wesfarmers Ltd (ASX: WES)
Finally, Wesfarmers is an ASX share I would buy and hold. It owns some of Australia's most recognisable retail businesses, including Bunnings, Kmart, Target, and Officeworks.
I think its strong market positions and ability to continually improve operations make it an excellent long-term investment.
Bunnings, for example, has enormous purchasing power and an extensive store network that would be difficult for competitors to replicate. Meanwhile, Kmart continues to benefit from its focus on affordable products and efficient operations.
These strengths helped Wesfarmers deliver an 8.3% increase in net profit excluding significant items to $2.9 billion in FY 2026, despite the tough economic environment.
Looking ahead, I believe its retail businesses have opportunities to increase sales, improve productivity, and expand their offerings. Combined with its growing healthcare operations and other investments, I think Wesfarmers could be a much bigger business by 2036.
The post 3 popular ASX shares I'd happily buy and hold until 2036 appeared first on The Motley Fool Australia.
Motley Fool contributor James Mickleboro has positions in REA Group and ResMed. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended ResMed and Wesfarmers. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool Australia has recommended Wesfarmers. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
The Motley Fool's purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool's free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson. 2026